LincRNA‐EPS inhibits the LPS‐induced production and activation of caspase‐11 and NLRP3 inflammasomes by suppressing the activation of the NF‐κB signalling pathway via interacting with TDP43, thereby alleviating periodontitis. The gene discussed is NLRP3; the disease is periodontitis.